Evidence map›Paper›PMID 40223054›Full record

ArticleRespiratory research2025

Integrative eQTL and Mendelian randomization analysis reveals key genetic markers in mesothelioma.

Jinsong Li, Xingmeng Wang, Yaru Lin, Zhengliang Li, Wei Xiong

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jinsong LiDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dali University, Dali, Yunnan, China.
Xingmeng WangDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dali University, Dali, Yunnan, China.
Yaru LinDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dali University, Dali, Yunnan, China.
Zhengliang LiDepartment of Radiology, The First Affiliated Hospital of Dali University, Dali University, Dali, Yunnan, China. 407874365@qq.com.
Wei XiongDepartment of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dali University, Dali, Yunnan, China. skyelijah201@gmail.com.

Funding

Key Program of Yunnan Provincial Applied Basic Research Program No. 202001BB0500080the National Natural Science Foundation of China Nos. 32160167 and 82160516Yunnan Provincial Applied Basic Research Program General Project Nos. 202201AT070004 and 202301AT070023
6 · The paper itself

Abstract

backgroundMesothelioma is a rare cancer that originates from the pleura and peritoneum, with its incidence increasing due to asbestos exposure. Patients are frequently diagnosed at advanced stages, resulting in poor survival rates. Therefore, the identification of molecular markers for early detection and diagnosis is essential.

methodsThree mesothelioma datasets were downloaded from the GEO database for differential gene expression analysis. Instrumental variables (IVs) were identified based on expression quantitative trait locus (eQTL) data for Mendelian randomization (MR) analysis using mesothelioma Genome-Wide Association Study (GWAS) data from the FINNGEN database. The intersecting genes from MR-identified risk genes and differentially expressed genes were identified as key co-expressed genes for mesothelioma. Functional enrichment analyses, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA), as well as immune cell correlation analysis, were performed to elucidate the roles of key genes in mesothelioma. Additionally, the differential expression of key genes in mesothelioma was validated in independent GEO datasets and TCGA datasets. This integrative research combining multiple databases and analytical methods established a robust model for identifying mesothelioma risk genes.

resultsThe research conducted in our study identified 1608 genes that were expressed differentially in mesothelioma GEO datasets. By combining these genes with 192 genes from MR analysis, we identified 14 key genes. Notably, MPZL1, SOAT1, TACC3, and CYBRD1 are linked to a high risk of mesothelioma, while TGFBR3, NDRG2, EPAS1, CPA3, MNDA, PRKCD, MTUS1, ALOX15, LRRN3, and ITGAM are associated with a lower risk. These genes were found to be enriched in pathways associated with superoxide metabolism, cell cycle regulation, and proteasome function, all of which are linked to the development of mesothelioma. Noteworthy observations included a significant infiltration of M1 macrophages and CD4 + T cells in mesothelioma, with genes SOAT1, MNDA, and ITGAM showing a positive correlation with the level of M1 macrophage infiltration. Furthermore, the differential expression analyses conducted on the GEO validation set and TCGA data confirmed the significance of the identified key genes.

conclusionThis integrative eQTL and Mendelian randomization analysis provides evidence of a positive causal association between 14 key co-expressed genes and mesothelioma genetically. These disease critical genes are implicated in correlations with biological processes and infiltrated immune cells related to mesothelioma. Moreover, our study lays a theoretical foundation for further research into the mechanisms of mesothelioma and potential clinical applications.

Indexed as

Biomarkers, TumorMendelian Randomization AnalysisMesotheliomaQuantitative Trait LociDatabases, GeneticGenetic MarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansBiomarkers, TumorGenetic MarkersBiomarkerseQTL localizationMendelian randomizationMesotheliomaTumor immunity

Identifiers

PMID40223054
PMCPMC11995628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.